These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 8009847)

  • 1. Expression and characterization of the two outer capsid proteins of African horsesickness virus: the role of VP2 in virus neutralization.
    Martinez-Torrecuadrada JL; Iwata H; Venteo A; Casal I; Roy P
    Virology; 1994 Jul; 202(1):348-59. PubMed ID: 8009847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective immunization of horses with a recombinant canarypox virus vectored vaccine co-expressing genes encoding the outer capsid proteins of African horse sickness virus.
    Guthrie AJ; Quan M; Lourens CW; Audonnet JC; Minke JM; Yao J; He L; Nordgren R; Gardner IA; Maclachlan NJ
    Vaccine; 2009 Jul; 27(33):4434-8. PubMed ID: 19490959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant baculovirus-synthesized African horsesickness virus (AHSV) outer-capsid protein VP2 provides protection against virulent AHSV challenge.
    Roy P; Bishop DH; Howard S; Aitchison H; Erasmus B
    J Gen Virol; 1996 Sep; 77 ( Pt 9)():2053-7. PubMed ID: 8811002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Full protection against African horsesickness (AHS) in horses induced by baculovirus-derived AHS virus serotype 4 VP2, VP5 and VP7.
    Martínez-Torrecuadrada JL; Díaz-Laviada M; Roy P; Sánchez C; Vela C; Sánchez-Vizcaíno JM; Casal JI
    J Gen Virol; 1996 Jun; 77 ( Pt 6)():1211-21. PubMed ID: 8683209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A first full outer capsid protein sequence data-set in the Orbivirus genus (family Reoviridae): cloning, sequencing, expression and analysis of a complete set of full-length outer capsid VP2 genes of the nine African horsesickness virus serotypes.
    Potgieter AC; Cloete M; Pretorius PJ; van Dijk AA
    J Gen Virol; 2003 May; 84(Pt 5):1317-1326. PubMed ID: 12692299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization with VP2 is sufficient for protection against lethal challenge with African horsesickness virus Type 4.
    Stone-Marschat MA; Moss SR; Burrage TG; Barber ML; Roy P; Laegreid WW
    Virology; 1996 Jun; 220(1):219-22. PubMed ID: 8659117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a linear neutralization domain in the protein VP2 of African horse sickness virus.
    Martínez-Torrecuadrada JL; Casal JI
    Virology; 1995 Jul; 210(2):391-9. PubMed ID: 7542417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VP2 Exchange and NS3/NS3a Deletion in African Horse Sickness Virus (AHSV) in Development of Disabled Infectious Single Animal Vaccine Candidates for AHSV.
    van de Water SG; van Gennip RG; Potgieter CA; Wright IM; van Rijn PA
    J Virol; 2015 Sep; 89(17):8764-72. PubMed ID: 26063433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination with recombinant Modified Vaccinia Ankara (MVA) viruses expressing single African horse sickness virus VP2 antigens induced cross-reactive virus neutralising antibodies (VNAb) in horses when administered in combination.
    Manning NM; Bachanek-Bankowska K; Mertens PPC; Castillo-Olivares J
    Vaccine; 2017 Oct; 35(44):6024-6029. PubMed ID: 28438410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of recombinant African horse sickness virus VP7 antigen via a simple method and validation of a VP7-based indirect ELISA for the detection of group-specific IgG antibodies in horse sera.
    Maree S; Paweska JT
    J Virol Methods; 2005 Apr; 125(1):55-65. PubMed ID: 15737417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural Protein VP2 of African Horse Sickness Virus Is Not Essential for Virus Replication In Vitro.
    van Gennip RGP; van de Water SGP; Potgieter CA; van Rijn PA
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27903804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cloning, characterization and expression of the gene that encodes the major neutralization-specific antigen of African horsesickness virus serotype 3.
    Vreede FT; Huismans H
    J Gen Virol; 1994 Dec; 75 ( Pt 12)():3629-33. PubMed ID: 7996157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. African horse sickness virus structure.
    Roy P; Mertens PP; Casal I
    Comp Immunol Microbiol Infect Dis; 1994; 17(3-4):243-73. PubMed ID: 8001348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutralizing epitopes of African horsesickness virus serotype 4 are located on VP2.
    Burrage TG; Trevejo R; Stone-Marschat M; Laegreid WW
    Virology; 1993 Oct; 196(2):799-803. PubMed ID: 7690505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein aggregation complicates the development of baculovirus-expressed African horsesickness virus serotype 5 VP2 subunit vaccines.
    du Plessis M; Cloete M; Aitchison H; Van Dijk AA
    Onderstepoort J Vet Res; 1998 Dec; 65(4):321-9. PubMed ID: 10192846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigenic profile of African horse sickness virus serotype 4 VP5 and identification of a neutralizing epitope shared with bluetongue virus and epizootic hemorrhagic disease virus.
    Martínez-Torrecuadrada JL; Langeveld JP; Venteo A; Sanz A; Dalsgaard K; Hamilton WD; Meloen RH; Casal JI
    Virology; 1999 May; 257(2):449-59. PubMed ID: 10329555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cloning, sequencing and expression of the gene that encodes the major neutralisation-specific antigen of African horsesickness virus serotype 9.
    Venter M; Napier G; Huismans H
    J Virol Methods; 2000 Apr; 86(1):41-53. PubMed ID: 10713375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of African horsesickness virus and discrimination between two equine orbivirus serogroups by reverse transcription polymerase chain reaction.
    Bremer CW; Viljoen GJ
    Onderstepoort J Vet Res; 1998 Mar; 65(1):1-8. PubMed ID: 9629584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An African horse sickness virus serotype 4 recombinant canarypox virus vaccine elicits specific cell-mediated immune responses in horses.
    El Garch H; Crafford JE; Amouyal P; Durand PY; Edlund Toulemonde C; Lemaitre L; Cozette V; Guthrie A; Minke JM
    Vet Immunol Immunopathol; 2012 Sep; 149(1-2):76-85. PubMed ID: 22763149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of recombinant VP2 proteins of all nine serotypes of African horse sickness virus.
    Kanai Y; van Rijn PA; Maris-Veldhuis M; Kaname Y; Athmaram TN; Roy P
    Vaccine; 2014 Sep; 32(39):4932-7. PubMed ID: 25045805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.